Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 40.26
+2.76 (7.36%)
Feb 13, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.89 billion as of February 13, 2026. Its market cap has increased by 65.87% in one year.
Market Cap
5.89B
Enterprise Value
4.37B
Revenue
478.69M
Ranking
n/a
PE Ratio
61.62
Stock Price
40.26
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.89B, a decrease of -28.40%. That is a compound annual growth rate of -7.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 5.89B | 6.56% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xiangxue Pharmaceutical | 6.21B |
| Kexing Biopharm | 6.10B |
| Lifecome Biochemistry | 5.85B |
| Shouyao Holdings (Beijing) Co., LTD. | 5.80B |
| Jiangsu Bioperfectus Technologies | 5.75B |
| ChemPartner PharmaTech | 5.56B |
| Wuhan Hvsen Biotechnology | 5.41B |
| Beijing Bohui Innovation Biotechnology Group | 5.29B |